Cover Image
市場調查報告書

中國的Esomeprazole市場分析

Investigation Report on China Esomeprazole Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 297281
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的Esomeprazole市場分析 Investigation Report on China Esomeprazole Market, 2010-2019
出版日期: 2015年05月28日 內容資訊: 英文 30 Pages
簡介

中國現在,有1億2000萬人患腸胃系統的疾病,其中的10%為消化性潰瘍,30%為慢性胃炎的患者。Esomeprazole(商品名「Nexium」)為由Astra Zeneca開發的抗潰瘍藥,在中國2004年上市,市場2005∼2014年以年複合成長率(CAGR)48%速度擴大。但由於對其高收益著眼的企業幾年相繼進入,今後一般認為市場佔有率將降低。

本報告提供中國的Esomeprazole的市場相關分析,中國國內的產量及醫院之銷售額、價格趨勢(過去5年份),各企業、各投藥形態的市場佔有率,未來性的市場趨勢預測(今後5年份)等調查,並將其結果為您概述為以下內容。

第1章 Esomeprazole的相關概念

  • 開發過程與症狀
  • 全球市場的銷售情形

第2章 中國的Esomeprazole市場概要

  • 主要製造商
  • 專利現況
  • 市場規模

第3章 Esomeprazole的銷售額分析

  • 總銷售額
  • 各地區的銷售額

第4章 主要廠商的市場佔有率分析

  • 市場佔有率(以金額為準)
  • 市場佔有率(以數量為準)

第5章 各劑型的市場規模分析

  • 各劑型的市場佔有率(以金額為準)
  • 各劑型的市場佔有率(以數量為準)

第6章 Esomeprazole的醫院之標準價格(各企業)

  • AstraZeneca(Wuxi)
  • AstraZeneca(Sweden)
  • Chongqing LUMMY Pharmaceutical Co., Ltd.

第7章 主要製造商分析

  • AstraZeneca(Wuxi)
  • AstraZeneca(Sweden)
  • Chongqing LUMMY Pharmaceutical Co., Ltd.

第8章 中國的Esomeprazole市場未來展望

  • 中國的消化器官疾病的發病趨勢
  • 學名藥現況
  • 市場規模的預測
  • 競爭模式的預測

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 1505180

Digestive system disease is one of frequently-occurring diseases. According to statistics of WHO, there are at least 250 million digestive tract patients, mainly suffering from canker.

Inhibition of gastric acid secretion is the key treatment method for peptic ulcer, duodenal ulcer and gastroesophageal reflux disease. The H+ / K+ ATP enzyme in gastric parietal cells can reduce gastric acid secretion. By inhibiting the functioning of this transporter, the drug prevents formation of gastric acid. Proton pump inhibitor, namely H+/K+-ATP enzyme, inhibits the avidity of H+/K+-ATP enzyme to block gastric acid secretion caused by any stimulation

Esomeprazole is a proton pump inhibitor that appeared on the market in 2000. It becomes popular in the market because of high bioavailability, effective and lasting inhibition of gastric acid and low toxic and side effect. Total sales revenue of Nexium (trade name of esomeprazole produced by Astra Zeneca) since it was launched is over tens of billions dollars, making it one of the most important products from Astra Zeneca. Patent No. 94190335. 4 is the most crucial patent for Nexium which expires in May 2014. To avoid time-consuming and costly patent infringement lawsuits, Astra Zeneca announced in October 2011 that generic drug manufacturers with cooperation intention needed to pay royalty before producing esomeprazole generic drugs. Though generic drugs take part of Nexium's market, Astra Zeneca can recoup the loss by charging patent royalty.

Statistics shows that there are over 120 million people suffering from enterogastric diseases in China, which is the most in the world. Incidence of peptic ulcer is 10% while that of chronic gastritis is 30%.

Nexium produced by Astra Zeneca entered China in 2004. According to CRI's investigation in China market, the CAGR of sales revenue of esomeprazole outstepped 48% from 2005 to 2014. In 2014, the sales value in sample hospital exceeded CNY 80 million, which was spectacularly successful. By the end of 2014, Chinese market was absolutely dominated by products from Astra Zeneca.

Chongqing LUMMY Pharmaceutical Co., Ltd. applied for 4 new drug registrations with esomeprazole in 2010, which was approved in August 2013. It is estimated that market pattern of esomeprazole in China will change in 2015. In the short term Nexium produced by Astra Zeneca will still have an absolute advantage in the market, but its market share will decline in the long run.

Through this report, the readers can acquire the following information:

  • Sales Price of Esomeprazole (Nexium) in China Hospital Market
  • Major Esomeprazole Manufacturers in China

Patent Status of Esomeprazole in China

  • Share of Esomeprazole in Different Dosage Forms in China Hospital Market
  • Prospect of China Esomeprazole Market

The Following Enterprises and People Are Recommended to Purchase This Report:

  • Manufacturers of Digestive System Diseases Medication
  • Investors on China Digestive System Diseases Drug Market

Table of Contents

1. Relevant Concepts of Esomeprazole

  • 1.1. Development Process and Indication
  • 1.2. Sales Status on the Global Market

2. Market Overview of Esomeprazole in China, 2010-2014

  • 2.1. Major Manufacturers
  • 2.2. Patent Status
  • 2.3. Market Size

3. Investigation on Sales Value of Esomeprazole in China, 2010-2014

  • 3.1. Total Sales Value
  • 3.2. Sales Value by Region

4. Investigation on Market Share of Major Esomeprazole Manufacturers in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Investigation on Market Size of Esomeprazole by Dosage Form in China, 2010-2014

  • 5.1. Market Share by Sales Value and Dosage Form
  • 5.2. Market Share by Sales Volume and Dosage Form

6. Reference Price of Esomeprazole Produced by Different Enterprises in China Hospital Market

  • 6.1. AstraZeneca(Wuxi)
  • 6.2. AstraZeneca(Sweden)
  • 6.3. Chongqing LUMMY Pharmaceutical Co., Ltd.

7. Major Manufacturers in China Esomeprazole Market, 2011-2014

  • 7.1. AstraZeneca(Wuxi)
  • 7.2. AstraZeneca(Sweden)
  • 7.3. Chongqing LUMMY Pharmaceutical Co., Ltd.

8. Market Prospect of Esomeprazole in China, 2014- 2018

  • 8.1. Digestive System Disease Incidence in China
  • 8.2. Status of Generic Drugs
  • 8.3. Forecast on Market Size
  • 8.4. Forecast on Competition Pattern

Selected Charts

  • Chart Esomeprazole Products Approved to Market in China by 2015
  • Chart Sales Value of Esomeprazole in Global Market, 2010-2014
  • Chart Esomeprazole Products Sold in China Market
  • Chart Patent Status of Esomeprazole in China
  • Chart Sales Value of Esomeprazole in Hospital Market in China, 2010-2014
  • Chart Sales Value of Esomeprazole by Region in China, 2010-2014
  • Chart Market Share of Esomeprazole Enterprises by Sales Value in China, 2010-2014
  • Chart Price of Esomeprazole Produced by AstraZeneca ( Wuxi) in China Hospital Market, 2014
  • Chart Forecast on Market Size of Hospital-use Esomeprazole in China, 2014-2018
Back to Top